CIBC Asset Management Inc lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 54.4% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 108,286 shares of the pharmacy operator's stock after selling 129,216 shares during the period. CIBC Asset Management Inc's holdings in Walgreens Boots Alliance were worth $970,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the company. Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Walgreens Boots Alliance by 21.8% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 25,343 shares of the pharmacy operator's stock valued at $227,000 after purchasing an additional 4,534 shares in the last quarter. OLD Second National Bank of Aurora lifted its stake in Walgreens Boots Alliance by 35.1% in the third quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator's stock valued at $41,000 after buying an additional 1,185 shares during the last quarter. Aptus Capital Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 37.6% in the third quarter. Aptus Capital Advisors LLC now owns 14,445 shares of the pharmacy operator's stock valued at $129,000 after buying an additional 3,950 shares during the last quarter. Aigen Investment Management LP purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at approximately $872,000. Finally, Rakuten Securities Inc. increased its stake in Walgreens Boots Alliance by 126.0% in the 3rd quarter. Rakuten Securities Inc. now owns 239,816 shares of the pharmacy operator's stock valued at $2,149,000 after buying an additional 133,684 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have commented on WBA. Evercore ISI raised their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an "in-line" rating in a report on Wednesday, October 16th. Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating for the company in a research note on Wednesday, September 4th. UBS Group increased their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a "neutral" rating in a research note on Thursday, October 17th. Jefferies Financial Group decreased their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. lowered their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating for the company in a research note on Friday, August 30th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $12.88.
Read Our Latest Research Report on WBA
Walgreens Boots Alliance Stock Performance
Shares of Walgreens Boots Alliance stock opened at $8.24 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The business has a fifty day simple moving average of $9.16 and a 200-day simple moving average of $11.67. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.11 and a fifty-two week high of $27.05.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business's revenue for the quarter was up 5.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.67 EPS. Research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.
Walgreens Boots Alliance Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 12.14%. Walgreens Boots Alliance's dividend payout ratio is currently -9.99%.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.